[Effect of thioctic acid (alpha-limpoic acid) on the chemotherapeutic efficacy of cyclophosphamide and vincristine sulfate].
Pretreatment with thioctic acid has no negative influence on the chemotherapeutic efficacy of cyclophosphamide against i.p. transplanted Yoshida sarcoma and vincristine sulfate against i.p. transplanted Walker carcinosarcoma 256. The toxic side effects of vincristine sulfate are lowered to such a degree that an increase results in median survival time compared to animals treated only with vincristine sulfate. A diminution of the toxic side effects of cyclophosphamide due to adjuvant treatment with thioctic acid could not be proven.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004347:Drug Interactions; D008297:Male; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D008063:Thioctic Acid / Q000494:pharmacology*; D014750:Vincristine / Q000627:therapeutic use*
D014750:Vincristine; D008063:Thioctic Acid; D003520:Cyclophosphamide
Einfluss von Thioctsäure (alpha-Liponsäure) auf die chemotherapeutische Wirkung von Cyclophosphamid und Vincaristinsulfat.